mepolizumab biosimilar
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 29, 2022
Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
(clinicaltrials.gov)
- P1 | N=88 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Rare Diseases • Vasculitis
1 to 1
Of
1
Go to page
1